Seeking Alpha

Jazz Pharmaceuticals (JAZZ) keeps soaring, now up 15.4% premarket after AH strength, on the...

Jazz Pharmaceuticals (JAZZ) keeps soaring, now up 15.4% premarket after AH strength, on the heels of landing EUSA Pharma and its leukemia drug for a cool $700M. The deal gives the company a larger global footprint.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector